Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Virginia Commonwealth University and Nicogen jointly divulge novel antismoking agents

Feb. 6, 2007

Canadian approval for Champix

Jan. 29, 2007

Suboxone available in U.K.

Jan. 26, 2007

ADX-10061 begins proof-of-concept study for smoking cessation

Jan. 26, 2007

elbion acquires product candidates from DrugAbuse Sciences

Jan. 25, 2007

Butyrylcholinesterase studied as chemical defense product in new phase I trial

Jan. 22, 2007

RX-100 shown to protect against lethal whole-body radiation

Jan. 17, 2007

Humanetics to begin phase I trials for BIO-300 for ARS

Jan. 15, 2007

Selegiline skin patch studied for smoking cessation

Jan. 12, 2007

Xytis signs CRADA for neboglamine in cocaine addiction

Jan. 9, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...